Abiopharma

🔍 CASPER MARC N (Director)

Company: THERMO FISHER SCIENTIFIC INC. (TMO)

Report Date: 2026-08-20

Detailed Transactions and Holdings:

• Acquired 10,000 shares of Common Stock at $309.63 per share (Direct)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 133,925.36 | transaction_form_type: 4
• Sold 909 shares of Common Stock at $625.45 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 133,016.36 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 821 shares of Common Stock at $626.83 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 132,195.36 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 1,314 shares of Common Stock at $627.66 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 130,881.36 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 2,601 shares of Common Stock at $628.82 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 128,280.36 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 1,250 shares of Common Stock at $629.85 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 127,030.36 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 1,035 shares of Common Stock at $630.87 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 125,995.36 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 1,430 shares of Common Stock at $632.01 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 124,565.36 | transaction_form_type: 4 | Footnotes: F1, F8
• Sold 560 shares of Common Stock at $632.94 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 124,005.36 | transaction_form_type: 4 | Footnotes: F1, F9
• Sold 80 shares of Common Stock at $633.99 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 123,925.36 | transaction_form_type: 4 | Footnotes: F1
• Acquired 10,000 shares of Common Stock at $309.63 per share (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 133,925.36 | transaction_form_type: 4
• Sold 2,727 shares of Common Stock at $625.46 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 131,198.36 | transaction_form_type: 4 | Footnotes: F1, F10
• Sold 3,014 shares of Common Stock at $626.51 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 128,184.36 | transaction_form_type: 4 | Footnotes: F1, F11
• Sold 1,791 shares of Common Stock at $627.39 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 126,393.36 | transaction_form_type: 4 | Footnotes: F1, F12
• Sold 2,147 shares of Common Stock at $628.61 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 124,246.36 | transaction_form_type: 4 | Footnotes: F1, F13
• Sold 321 shares of Common Stock at $629.1 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 123,925.36 | transaction_form_type: 4 | Footnotes: F1, F14
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-20 | Code: H | nature_of_ownership: By Alison Casper 2020 Irrevocable Trust | shares_owned_after: 11,300.00 | Footnotes: F15
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-20 | Code: H | nature_of_ownership: By MNC 2020 Irrevocable Trust | shares_owned_after: 5,000.00 | Footnotes: F15
• Sold 10,000 shares of Stock Option (Right to Buy) at $309.63 per share (Derivative)
  Date: 2026-08-20 | Code: M | Expires: 2027-02-25 | equity_swap_involved: 0 | shares_owned_after: 10,275.00 | transaction_form_type: 4 | Footnotes: F16
• Sold 10,000 shares of Stock Option (Right to Buy) at $309.63 per share (Derivative)
  Date: 2026-08-21 | Code: M | Expires: 2027-02-25 | equity_swap_involved: 0 | shares_owned_after: 275.00 | transaction_form_type: 4 | Footnotes: F16

Footnotes:

• F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 27, 2026.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $625.00 to $625.80, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13) and (14) to this Form 4.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $626.17 to $627.08, inclusive.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $627.33 to $628.29, inclusive.
• F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $628.36 to $629.33, inclusive.
• F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $629.41 to $630.37, inclusive.
• F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $630.47 to $631.37, inclusive.
• F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $631.52 to $632.44, inclusive.
• F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $632.60 to $633.32, inclusive.
• F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $625.00 to $625.97, inclusive.
• F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $626.00 to $626.99, inclusive.
• F12: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $627.00 to $627.99, inclusive.
• F13: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $628.00 to $628.94, inclusive.
• F14: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $629.00 to $629.20, inclusive.
• F15: The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
• F16: The option vested in four equal installments on February 25, 2021, 2022, 2023, and 2024.